Novel autoantibody against DAGLA discovered in cerebellitis

Diacylglycerol lipase alpha (DAGLA) has been identified as a novel autoantibody target in patients with rapid progressive cerebellar ataxia. The autoantibodies were characterised as part of a collaborative study between scientists at EUROIMMUN (Lübeck, Germany), the Hannover Medical School, (Hannover, Germany) and further institutes and clinics. The study was published in April 2024 the journal […]


Antibody testing reduces dengue vaccination risk

As the COVID-19 pandemic has recently demonstrated, vaccinations are one of the most important and effective preventive measures in medicine for the protection against an infectious disease. Dengue fever is one of the most common infectious diseases worldwide, but often underestimated. Dengue fever is caused by dengue virus (DENV) which is, among others, spread to


Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Press release Lübeck, 25 April 2024 Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof’s


Our solutions for maximum blot efficiency!

With the introduction of the EUROMicroblots last year, we miniaturised our successful blot technology to the size of a microplate well to make processing even more efficient and to save resources. The perfect device to match: Our compact Microwell Imager. The benchtop device for image acquisition of EUROMicroblots works at a speed of one image


Let’s embark on a new journey together!

Get started with us as a trusted partner on the way to a simple and reliable routine for your allergy diagnostics! The (ChLIA) journey begins The use of chemiluminescence immunoassays (ChLIAs) in allergy diagnostics is not new. However, finding a suitable, reliable and simple random-access solution can sometimes be difficult. This is where our IDS-iSYS

Scroll to Top